HBV-IN-39-d3
Modify Date: 2024-09-12 12:40:17
HBV-IN-39-d3 structure
|
Common Name | HBV-IN-39-d3 | ||
|---|---|---|---|---|
| CAS Number | 2173356-23-3 | Molecular Weight | 436.49 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C23H25D3FNO6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of HBV-IN-39-d3HBV-IN-39-d3 (Example 14) is a deuterated HBV-IN-39 (Example 13). HBV-IN-39 is an HBV inhibitor. HBV-IN-39-d3 has better oral bioavailability than HBV-IN-39[1]. |
| Name | HBV-IN-39-d3 |
|---|
| Description | HBV-IN-39-d3 (Example 14) is a deuterated HBV-IN-39 (Example 13). HBV-IN-39 is an HBV inhibitor. HBV-IN-39-d3 has better oral bioavailability than HBV-IN-39[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Yi Chen, et al. Therapeutic agents for the treatment of HBV infection. Patent CN110240596B. |
| Molecular Formula | C23H25D3FNO6 |
|---|---|
| Molecular Weight | 436.49 |